Tonix Pharmaceuticals Holding Corp (TNXP)
0.2042
+0.01
(+7.47%)
USD |
NASDAQ |
Nov 21, 16:00
0.1895
-0.01
(-7.20%)
After-Hours: 05:51
Tonix Pharmaceuticals Profit Margin (Quarterly): -503.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -503.6% |
| June 30, 2024 | -3.57K% |
| March 31, 2024 | -601.9% |
| Date | Value |
|---|---|
| December 31, 2023 | -723.0% |
| September 30, 2023 | -701.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.57K%
Minimum
Jun 2024
-503.6%
Maximum
Sep 2024
-1.22K%
Average
-701.3%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 40.45% |
| Geovax Labs Inc | -208.5% |
| Abbott Laboratories | 15.48% |
| Amicus Therapeutics Inc | -4.75% |
| United Therapeutics Corp | 41.27% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -150.0% |
| Return on Assets | -113.8% |
| Return on Invested Capital | -139.4% |
| Gross Profit Margin (Quarterly) | 44.90% |
| Operating Margin (Quarterly) | -492.1% |
| Return on Net Operating Assets | -140.1% |